Prevention of Encrustation on Ureteral Stents: Which Surface Parameters Provide Guidance for the Development of Novel Stent Materials?
encrustation
polymer
ureteral stent
urothelial cells
wettability
zeta potential
Journal
Polymers
ISSN: 2073-4360
Titre abrégé: Polymers (Basel)
Pays: Switzerland
ID NLM: 101545357
Informations de publication
Date de publication:
03 Mar 2020
03 Mar 2020
Historique:
received:
07
02
2020
revised:
28
02
2020
accepted:
01
03
2020
entrez:
7
3
2020
pubmed:
7
3
2020
medline:
7
3
2020
Statut:
epublish
Résumé
Encrustations of ureteral stents are one of the biggest problems with urological implants. Crystalline biofilms can occur alone or in combination with bacterial biofilms. To identify which surface parameters provide guidance for the development of novel stent materials, we used an in vitro encrustation system. Synthetic urine with increasing pH to simulate an infection situation was pumped over the polymer samples with adjusted flow rates at 37 °C to mimic the native body urine flow. Chemical surface features (contact angle, surface charge), as well as encrustations were characterized. The encrustations on the materials were analyzed quantitatively (dry mass) and qualitatively using scanning electron microscopy (SEM), energy dispersive X-ray spectroscopy (EDX), and Fourier transform infrared spectroscopy (FTIR). The aim of this comparative study was to identify crucial surface parameters that might predict the quantity and type of mineral deposits in vitro and provide guidance for the development and screening of new polymer-based biomaterials for ureteral stent design. For the first time, we could identify that, within the range of our polymers, those materials with a slight hydrophilicity and a strong negative zeta potential (around -60 mV) were most favorable for use as ureteral stent materials, as the deposition of crystalline biofilms was minimized.
Identifiants
pubmed: 32138300
pii: polym12030558
doi: 10.3390/polym12030558
pmc: PMC7182952
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Bundesministerium für Bildung und Forschung
ID : 13GW0109D
Références
J Intern Med. 2014 Aug;276(2):120-9
pubmed: 24635559
J Healthc Eng. 2018 Oct 14;2018:2986742
pubmed: 30405898
Int J Antimicrob Agents. 2002 Jun;19(6):488-98
pubmed: 12135839
J Urol. 1989 Nov;142(5):1347-50
pubmed: 2553997
Int J Antimicrob Agents. 2002 Jun;19(6):507-10
pubmed: 12135841
Urol Int. 2002;68(1):54-9
pubmed: 11803269
Biomed Tech (Berl). 2016 Oct 1;61(5):483-490
pubmed: 26943591
Am J Med. 2002 Jul 8;113 Suppl 1A:5S-13S
pubmed: 12113866
Pediatr Nephrol. 2010 May;25(5):831-41
pubmed: 19198886
Water Res. 2007 Jan;41(2):419-25
pubmed: 17140618
Cochrane Database Syst Rev. 2007 Jul 18;(3):CD004997
pubmed: 17636782
BJU Int. 2000 Sep;86(4):414-21
pubmed: 10971264
Invest Urol. 1976 Mar;13(5):346-50
pubmed: 815197
Kidney Int. 1978 May;13(5):372-82
pubmed: 351265
Arch Esp Urol. 2016 Oct;69(8):485-493
pubmed: 27725325
J Hosp Infect. 1988 Apr;11(3):253-62
pubmed: 2899109
J Biomed Mater Res B Appl Biomater. 2008 Nov;87(2):590-7
pubmed: 18506826
Biomaterials. 1996 Aug;17(15):1541-6
pubmed: 8853126
Nat Clin Pract Urol. 2004 Nov;1(1):44-8
pubmed: 16474466
Int J Urol. 2019 Feb;26(2):172-183
pubmed: 30575154
Pathol Res Pract. 2003;199(5):329-35
pubmed: 12908523
J Urol. 2011 Apr;185(4):1304-11
pubmed: 21334658
Nephron. 2001 Aug;88(4):320-8
pubmed: 11474226